Skip to main content

Published locations for Dapagliflozin meets endpoint in top-line DECLARE results, AstraZeneca says

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dapagliflozin meets endpoint in top-line DECLARE results, AstraZeneca says

User login

  • Reset your password
  • /content/dapagliflozin-meets-endpoint-top-line-declare-results-astrazeneca-says
  • /clinicalendocrinologynews/article/175645/diabetes/dapagliflozin-meets-endpoint-top-line-declare
  • /ecardiologynews/article/175645/diabetes/dapagliflozin-meets-endpoint-top-line-declare-results
  • /cardiology/article/175645/diabetes/dapagliflozin-meets-endpoint-top-line-declare-results-astrazeneca
  • /endocrinology/article/175645/diabetes/dapagliflozin-meets-endpoint-top-line-declare-results
  • /type-2-diabetes-icymi/article/175645/diabetes/dapagliflozin-meets-endpoint-top-line-declare-results